About
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Patients and caregivers
Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.
Healthcare professionals
Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.
Research & development
Discover how Novartis turns breakthrough science into transformative, high-value treatments.
Environmental, social and governance
Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.
Investors
Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.
News
Information for journalists including media releases, statements, stories, multimedia resources and more.
Careers
Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.
Home
Working together, we can reimagine medicine to improve and extend people’s lives.
Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Novartis announced it has partnered with Versant Ventures (Versant) to form Borealis Biosciences (Borealis), an independent, discovery-stage biotechnology company based in Vancouver, Canada, focused on developing next-generation xRNA-based medicines for kidney diseases. xRNA, a core technology platform for Novartis, can target the body’s natural mRNA to modulate the production of proteins that cause disease.
Novartis announced the company’s financial results for the second quarter and first half of 2024.
Novartis announced the company’s financial results for the first quarter of 2024.
Novartis announces the company’s fourth quarter and 2023 full year financial results.
Latest news and interviews for media and investors
Novartis poised to expand impact on human health as it begins next era.
Novartis announced the company’s financial results for the second quarter and first half of 2023.
Novartis announced the company’s financial results for the first quarter of 2023.
Novartis announces the company’s fourth quarter and 2022 full year financial results.
